Pay in 4 interest-free payments of $8.75 Learn more
Ships within 48 hours · Estimated delivery Oct 10 - Oct 15
a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo
287(13):9742-52
shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
ATB-346 exerts superior chemopreventive effects to those of naproxen
ent-crizotinib
AG-221 (Enasidenib) - IHD2 Inhibitor. CAS# 1446502-11-9 size:Contact [email protected] for quotation a potent inhibitor of mitogen-activatedEnasidenib, also known as AG 221 and CC 90007, CAS No. 1446502 11 9, is a potent and selective IDH2 inhibitor with potential anticancer activity (IDH2 = Isocitrate dehydrogenase 2). The mutations of IDH2 present in certain cancer cells result in a new ability of the enzyme to catalyze the NAPH dependent reduction of ketoglutarate to R( ) 2 hydroxyglutarate (2HG). The production of 2HG is believed to contribute to the formation and progression of
US$ 397.50
US$ 397.50
US$ 397.50
US$ 397.50
US$ 397.50
US$ 354.98
US$ 397.50
US$ 397.50
US$ 397.50
US$ 354.98
US$ 397.50
US$ 397.50
US$ 397.50
US$ 397.50